help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PLATTS-MILLS, T. A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PLATTS-MILLS, T. A. E.

Am. J. Respir. Crit. Care Med., Volume 164, Number 8, October 2001, S1-S5

The Role of Immunoglobulin E in Allergy and Asthma

THOMAS A. E. PLATTS-MILLS

Division of Allergy and Immunology, University of Virginia, Charlottesville, Virginia

It has been nearly a century since the first suggestion that a soluble factor in plasma or serum might be responsible for the symptoms of allergic disease and asthma, and more than 30 yr since immunoglobulin E (IgE) was identified as the key molecule in mediating what are now described as type 1 hypersensitivity reactions (allergic asthma, allergic rhinitis, food allergy, atopic dermatitis, some forms of drug allergy, and insect sting allergy). Since that time, many of the details of the inflammatory cascade underlying allergy and asthma have been elucidated, and IgE is now known to play a key upstream role. The goals of this report are to review the cellular and molecular events set in motion by IgE and to examine the evidence for its participation in both the immediate allergic response and the late-phase or chronic inflammatory response in the skin and lungs.




This article has been cited by other articles:


Home page
 ERRHome page
J. Bousquet, U. Wahn, E. O. Meltzer, H. Fox, S. Hedgecock, K. Thomas, and A. Fowler-Taylor
Omalizumab: an anti-immunoglobulin E antibody for the treatment of allergic respiratory diseases
Eur. Respir. Rev., April 1, 2008; 17(107): 1 - 9.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
N. A. Hanania
Targeting Airway Inflammation in Asthma: Current and Future Therapies
Chest, April 1, 2008; 133(4): 989 - 998.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
A. M. Barrio, D. Soeria-Atmadja, A. Nister, M. G. Gustafsson, U. Hammerling, and E. Bongcam-Rudloff
EVALLER: a web server for in silico assessment of potential protein allergenicity
Nucleic Acids Res., July 13, 2007; 35(suppl_2): W694 - W700.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
D. Soeria-Atmadja, T. Lundell, M. G. Gustafsson, and U. Hammerling
Computational detection of allergenic proteins attains a new level of accuracy with in silico variable-length peptide extraction and machine learning
Nucleic Acids Res., August 29, 2006; 34(13): 3779 - 3793.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Suto, H. Nakajima, K. Hirose, K. Suzuki, S.-i. Kagami, Y. Seto, A. Hoshimoto, Y. Saito, D. C. Foster, and I. Iwamoto
Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line Cepsilon transcription of IL-4-stimulated B cells
Blood, December 15, 2002; 100(13): 4565 - 4573.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society 		  Tobacco